Citations (8)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Peng Zhao, Yuanzhong Xu, Xuejun Fan, Leike Li, Xin Li, Hisashi Arase, Qingchun Tong, Ningyan Zhang & Zhiqiang An. (2022) Discovery and engineering of an anti-TREM2 antibody to promote amyloid plaque clearance by microglia in 5XFAD mice. mAbs 14:1.
Read now
Read now
Articles from other publishers (7)
Yilin Gu, Zhijia Wang & Yuxi Wang. (2024) Bispecific antibody drug conjugates: Making 1+1>2. Acta Pharmaceutica Sinica B 14:5, pages 1965-1986.
Crossref
Crossref
Christian Klein, Ulrich Brinkmann, Janice M. Reichert & Roland E. Kontermann. (2024) The present and future of bispecific antibodies for cancer therapy. Nature Reviews Drug Discovery 23:4, pages 301-319.
Crossref
Crossref
Qi Yang, Zhao Chen, Yongkang Qiu, Wenpeng Huang, Tianyao Wang, Lele Song, Xinyao Sun, Cuicui Li, Xiaojie Xu & Lei Kang. (2023) Theranostic role of 89Zr- and 177Lu-labeled aflibercept in breast cancer. European Journal of Nuclear Medicine and Molecular Imaging 51:5, pages 1246-1260.
Crossref
Crossref
Ravi Raj Singh, Indranil Mondal, Taskeen Janjua, Amirali Popat & Ritu Kulshreshtha. (2024) Engineered smart materials for RNA based molecular therapy to treat Glioblastoma. Bioactive Materials 33, pages 396-423.
Crossref
Crossref
Rebecca Faresjö, Dag Sehlin & Stina Syvänen. (2023) Age, dose, and binding to TfR on blood cells influence brain delivery of a TfR-transported antibody. Fluids and Barriers of the CNS 20:1.
Crossref
Crossref
Mariachiara Buccarelli, Giorgia Castellani & Lucia Ricci-Vitiani. (2022) Glioblastoma-Specific Strategies of Vascularization: Implications in Anti-Angiogenic Therapy Resistance. Journal of Personalized Medicine 12:10, pages 1625.
Crossref
Crossref
Peng Zhao, Ningyan Zhang & Zhiqiang An. (2022) Engineering antibody and protein therapeutics to cross the blood–brain barrier. Antibody Therapeutics 5:4, pages 311-331.
Crossref
Crossref